Search Results - "Zanaboni, Flavia"

Clinical and pathological prognostic factors in squamous cell carcinoma of the vulva by Raspagliesi, Francesco, Hanozet, Francesco, Ditto, Antonino, Solima, Eugenio, Zanaboni, Flavia, Vecchione, Francesca, Kusamura, Shigeki

“…The objective of this study was the prognostic analysis of clinicopathologic variables related to primary tumor and to lymph node metastases. We…”
Get full text

Trabectedin for Women With Ovarian Carcinoma After Treatment With Platinum and Taxanes Fails by SESSA, Cristiana, DE BRAUD, Filippo, D'INCALCI, Maurizio, DALL'O, Elisa, COLOMBO, Nicoletta, PEROTTI, Antonella, BAUER, Jean, CURIGLIANO, Giuseppe, NOBERASCO, Cristina, ZANABONI, Flavia, GIANNI, Luca, MARSONI, Silvia, JIMENO, José

“…To assess the efficacy and toxicity of the marine-derived alkaloid trabectedin (ET-743) in patients with advanced ovarian cancer refractory to or experiencing…”
Get full text

Role of paclitaxel and cisplatin as the neoadjuvant treatment for locally advanced squamous cell carcinoma of the vulva by Raspagliesi, Francesco, Zanaboni, Flavia, Martinelli, Fabio, Scasso, Santiago, Laufer, Joel, Ditto, Antonino

“…The therapeutic outcomes of patients with advanced vulvar cancer are poor. Multi-modality treatments including concurrent chemoradiation or different regimens…”
Get full text

Implementation of laparoscopic approach for type B radical hysterectomy: A comparison with open surgical operations by Ditto, Antonino, Martinelli, Fabio, Bogani, Giorgio, Gasparri, Maria L, Di Donato, Violante, Zanaboni, Flavia, Lorusso, Domenica, Raspagliesi, Francesco

“…Abstract Objective To investigate the safety, feasibility and effectiveness of laparoscopic approach in the management patients undergoing modified radical…”
Get full text

Nerve-sparing radical hysterectomy: a pilot study by Raspagliesi, Francesco, Ditto, Antonino, Kusamura, Shigeki, Fontanelli, Rosanna, Spatti, Gianbattista, Solima, Eugenio, Zanaboni, Flavia, Carcangiu, Maria L

“…Nerve-sparing radical hysterectomy has increasingly been used for cervical cancer, with less morbidity. We aimed with this study: i) to describe an alternative…”
Get full text

Phase II trial on cisplatin-adriamycin-paclitaxel combination as neoadjuvant chemotherapy for locally advanced cervical adenocarcinoma by Lorusso, Domenica, Ramondino, Stefano, Mancini, Maria, Zanaboni, Flavia, Ditto, Antonino, Raspagliesi, Francesco

“…Neoadjuvant chemotherapy (NACT) followed by surgery is a different therapeutic approach to locally advanced cervical adenocarcinoma (LACA) and seems to offer…”
Get more information

Determinants of Response to a Cisplatin-Based Regimen as Neoadjuvant Chemotherapy in Stage IB–IIB Invasive Cervical Cancer by Bolis, Giorgio, van Zainten-Przybysz, Iwona, Scarfone, Giovanna, Zanaboni, Flavia, Scarabelli, Claudio, Tateo, Saverio, Calabrese, Marcella, Parazzini, Fabio

“…The response rate and the determinants of response to a cisplatin-based regimen of neodjuvant chemoterapy (NACT) in women with a histologically confirmed…”
Get full text

Type II versus Type III Nerve-sparing Radical hysterectomy: Comparison of lower urinary tract dysfunctions by Raspagliesi, Francesco, Ditto, Antonino, Fontanelli, Rosanna, Zanaboni, Flavia, Solima, Eugenio, Spatti, Gianbattista, Hanozet, Francesco, Vecchione, Francesca, Rossi, Gabriella, Kusamura, Shigeki

“…According to our previous experience, Type III Nerve-sparing Radical hysterectomy (NSRH) for cervical cancer presented an acceptable urologic morbidity,…”
Get full text

Class III NSRH: Oncological outcome in 170 cervical cancer patients by Ditto, Antonino, Martinelli, Fabio, Hanozet, Francesco, Reato, Claudio, Solima, Eugenio, Zanaboni, Flavia, Grijuela, Barbara, Carcangiu, Marialuisa, Haeusler, Edward, Raspagliesi, Francesco

“…Abstract Objective To analyze local recurrence rate (LRR), morbidities and oncologic outcome of class III nerve-sparing radical hysterectomy. Patients and…”
Get full text

Quality of life and sexual, bladder, and intestinal dysfunctions after class III nerve-sparing and class II radical hysterectomies: a questionnaire-based study by Ditto, Antonino, Martinelli, Fabio, Borreani, Claudia, Kusamura, Shigeki, Hanozet, Francesco, Brunelli, Cinzia, Rossi, Gabriela, Solima, Eugenio, Fontanelli, Rosanna, Zanaboni, Flavia, Grijuela, Barbara, Raspagliesi, Francesco

“…To compare quality of life and bladder, intestinal, and sexual dysfunctions in 2 groups of patients undergoing different types of radical hysterectomies (RHs)…”
Get more information

Nerve-sparing radical hysterectomy in cervical cancer: Evolution of concepts by Raspagliesi, Francesco, Ditto, Antonino, Hanozet, Francesco, Martinelli, Fabio, Solima, Eugenio, Zanaboni, Flavia, Kusamura, Shigeki, Fontanelli, Rosanna

“…Abstract Objectives This paper reviews the evolution of concepts concerning the nerve-sparing radical hysterectomy (NSRH) in cervical cancer. Methods Research…”
Get full text

Nerve-sparing radical hysterectomy: a surgical technique for preserving the autonomic hypogastric nerve by Raspagliesi, Francesco, Ditto, Antonino, Fontanelli, Rosanna, Solima, Eugenio, Hanozet, Francesco, Zanaboni, Flavia, Kusamura, Shigeki

“…Objectives. Recently, a nerve-sparing radical hysterectomy has been proposed for cervical cancer to reduce morbidity. The aim of this study is (i) to describe…”
Get full text

Phase II trial on cisplatin-doxorubicin hydrochloride-paclitaxel (TAP) combination as neoadjuvant chemotherapy (NACT) for locally advanced cervical adenocarcinoma (LACA) by Raspagliesi, Francesco, Ramondino, Stefano, Zanaboni, Flavia, Ditto, Antonino, Solima, Eugenio, Grijuela, Barbara, Spatti, Gian Battista, Gabbanini, Massimo, Mancini, Maria, Martinelli, Fabio, Amaya De Carrillo, Carla, Fontanelli, Rosanna, Lorusso, Domenica

“…Abstract only 5096 Background: NACT followed by surgery is a different therapeutic approach to locally advanced cervical cancer that seems to offer specific…”
Get full text

CA 125 reliability in predicting ovarian cancer recurrence by Zanaboni, F, Presti, M, Scarfone, G, Bolis, G

“…The predictive value of CA 125 assay for recurrence in ovarian cancer patients in follow-up was analyzed in a study from April 1984 through June 1987…”
Get more information

Gemcitabine combined with oxaliplatin (GEMOX) as second-line chemotherapy in patients with advanced ovarian cancer refractory or resistant to platinum and taxane by Raspagliesi, Francesco, Zanaboni, Flavia, Vecchione, Francesca, Hanozet, Francesco, Scollo, Paolo, Ditto, Antonino, Grijuela, Barbara, Fontanelli, Rosanna, Solima, Eugenio, Spatti, Gianbattista, Scibilia, Giuseppe, Kusamura, Shigeki

“…The aim of this multicenter feasibility study was to determine the toxicity profile and antitumor activity of the gemcitabine plus oxaliplatin combination as…”
Get more information

Clinical Value of Intraoperative Gross Examination in Endometrial Cancer by Franchi, Massimo, Ghezzi, Fabio, Melpignano, Mauro, Cherchi, Pier Luigi, Scarabelli, Claudio, Apolloni, Chiara, Zanaboni, Flavia

“…We present the largest multicenter study evaluating whether intraoperative visual estimation can accurately assess the depth of myometrial invasion in patients…”
Get full text

Clinical and Pathological Prognostic Factors in Squamous Cell Carcinoma of the Vulva by Raspagliesi, Francesco, Hanozet, Francesco, Ditto, Antonino, Solima, Eugenio, Zanaboni, Flavia, Vecchione, Francesca, Kusamura, Shigeki

“…Approximately 4% of gynecologic cancers are invasive carcinomas of the vulva. This retrospective study was intended to determine the prognostic importance of…”
Get full text

Nonclosure of peritoneum at radical abdominal hysterectomy and pelvic node dissection: A randomized study by Franchi, Massimo, Ghezzi, Fabio, Zanaboni, Flavia, Scarabelli, Claudio, Beretta, Paolo, Donadello, Nicoletta

“…To compare closure and nonclosure of the peritoneum at radical abdominal hysterectomy and pelvic node dissection with respect to postoperative morbidity. Women…”
Get full text

Endometrial thickness in tamoxifen-treated patients: an independent predictor of endometrial disease by Franchi, Massimo, Ghezzi, Fabio, Donadello, Nicoletta, Zanaboni, Flavia, Beretta, Paolo, Bolis, Pierfrancesco

“…Objective: To assess the independent contribution of transvaginal ultrasound in identifying women at risk for endometrial disorders, and determine whether a…”
Get full text

Octreotide in the Management of Bowel Obstruction in Terminal Ovarian Cancer by Mangili, Giorgia, Franchi, Massimo, Mariani, Andrea, Zanaboni, Flavia, Rabaiotti, Emanuela, Frigerio, Luigi, Bolis, Pier Francesco, Ferrari, Augusto

“…Intestinal obstruction is a common and distressing clinical complication in ovarian cancer. The aim of our study was to assess vomit control in terminal…”
Get full text